| Title: |
Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey study |
| Authors: |
Ahmed, K.; Holloway, I.; Absolom, K.; Mason, S.J.; Mujica-Mota, R.; Gkountouras, G.; Martin, A.; Flannery, T.; Richards, M.; Astwood, E.; Ackroyd, S.; Greystoke, B.; Greenfield, D.M.; Hill, Q.; James, B.; Kwok- Williams, M.; Murray, R.D.; Samuelson, C.; Simcox, D.; Snowden, J.A.; Sharif, J.; Sadasivam, N.; Feltbower, R.; Glaser, A. |
| Publisher Information: |
BMJ |
| Publication Year: |
2026 |
| Collection: |
White Rose Research Online (Universities of Leeds, Sheffield & York) |
| Description: |
Introduction Recent advances in treatment and care have improved survival rates for children and young adults with severe blood disorders such as sickle cell disease (SCD), transfusion-dependent beta-thalassaemia (TDT) and acute leukaemia. However, their quality of life and reproductive and psychosocial outcomes are not yet well studied. For SCD and TDT, robust survival data are mainly limited to North America. Thus, there is a need to fill these knowledge gaps to guide improvements in care, address unmet clinical needs and rigorously assess the efficacy of emerging novel therapies. Methods and analysis This is an observational population-based mixed-methods study of individuals diagnosed with SCD, TDT or acute leukaemia when under the age of 18 in England, involving a data linkage component and a patient-reported outcomes measures survey. Data linkage-eligible participants will be identified from national and regional databases, including the Hospital Episode Statistics, Yorkshire Specialist Register of Cancer in Children & Young People and the National Congenital Anomaly and Rare Diseases Registration Service. Data linkage will be processed within the NHS England and the University of Leeds’ secure, trusted research environments. Data will be accessed without consent under section 251 and approval by the confidentiality advisory group. It will assess survival rates for SCD and TDT as well as clinical, educational and mental health outcomes for SCD, TDT and acute leukaemia diagnosed in childhood. Survey-eligible participants for SCD, TDT and acute leukaemia cohorts will be checked for their suitability to participate by the North of England clinical care teams. An NHS-approved survey provider will facilitate data checks with the NHS National Data Opt-Out Service. Consent is required for participation in the survey and for subsequent data linkage to existing databases. Surveys are conducted in various formats (online, paper and phone), with reminders sent after 21 days. The survey will assess quality of life ... |
| Document Type: |
article in journal/newspaper |
| File Description: |
text |
| Language: |
English |
| ISSN: |
2044-6055 |
| Relation: |
https://eprints.whiterose.ac.uk/id/eprint/237671/1/Ahmed%20et%20al%20BMJ%20Open%202026%20.pdf; Ahmed, K., Holloway, I., Absolom, K. orcid.org/0000-0002-5477-6643 et al. (21 more authors) (2026) Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey study. BMJ Open, 16 (2). e111664. ISSN: 2044-6055 |
| Availability: |
https://eprints.whiterose.ac.uk/id/eprint/237671/; https://eprints.whiterose.ac.uk/id/eprint/237671/1/Ahmed%20et%20al%20BMJ%20Open%202026%20.pdf |
| Rights: |
cc_by_nc_4 |
| Accession Number: |
edsbas.444A78C8 |
| Database: |
BASE |